Assembly Biosciences (NASDAQ:ASMB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Assembly Biosciences (ASMB) operate in?

Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 28.48K
Day Range	- - -
52 Wk Range	7.69 - 19.93
Market Cap	$104.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	0.18%
Days to Cover	1

Recent News

Assembly Biosciences' Investigational Herpes Treatment Shows Safety In Healthy Participants (UPDATED)

Assembly Biosciences reported interim results from its Phase 1a study of ABI-5366, a long-acting HSV inhibitor for recurrent genital herpes. The drug showed a favorable safety profile and achieved target plasma concentrations for antiviral efficacy.

Vandana Singh

Insiders Buying American Software And 2 Other Stocks

Avi Kapoor

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 28.48K
Day Range	- - -
52 Wk Range	7.69 - 19.93
Market Cap	$104.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	0.18%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Assembly Biosciences (ASMB) stock?

You can purchase shares of Assembly Biosciences (NASDAQ:ASMB) through any online brokerage.

View our list of the best stock brokerages

Who are Assembly Biosciences (ASMB) competitors?

Other companies in Assembly Biosciences’s space includes: Innate Pharma (NASDAQ:IPHA), Anixa Biosciences (NASDAQ:ANIX), Monopar Therapeutics (NASDAQ:MNPR), Inovio Pharmaceuticals (NASDAQ:INO) and Century Therapeutics (NASDAQ:IPSC).

What is the forecast, or price target, for Assembly Biosciences (ASMB) stock?

Assembly Biosciences has a consensus price target of $13.33.

What is the current price for Assembly Biosciences (ASMB)?

The stock price for Assembly Biosciences (NASDAQ: ASMB) is $16.5 last updated November 15, 2024 at 5:23 AM EST.

Does Assembly Biosciences (ASMB) pay a dividend?

There are no upcoming dividends for Assembly Biosciences.

When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?

Assembly Biosciences’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Assembly Biosciences (ASMB) going to split?

There is no upcoming split for Assembly Biosciences.

What sector and industry does Assembly Biosciences (ASMB) operate in?

Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Assembly Biosciences

Assembly Biosciences (ASMB) Forecast